The multipartite system that mediates entry of herpes simplex virus into the cell.
about
Izumo is part of a multiprotein family whose members form large complexes on mammalian spermViral entry mechanisms: cellular and viral mediators of herpes simplex virus entryOcular diseases: immunological and molecular mechanismsRetargeting Strategies for Oncolytic Herpes Simplex VirusesThe ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirusA 3D model of the membrane protein complex formed by the white spot syndrome virus structural proteinsReevaluating herpes simplex virus hemifusion.Effect of ultrasound on herpes simplex virus infection in cell culture.Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infectionInsertion mutations in herpes simplex virus 1 glycoprotein H reduce cell surface expression, slow the rate of cell fusion, or abrogate functions in cell fusion and viral entry.Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins.Herpes simplex virus glycoproteins H/L bind to cells independently of {alpha}V{beta}3 integrin and inhibit virus entry, and their constitutive expression restricts infectionExploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization.Glycoprotein D of bovine herpesvirus 5 (BoHV-5) confers an extended host range to BoHV-1 but does not contribute to invasion of the brainDendritic cells: key players in human herpesvirus 8 infection and pathogenesis.Herpes simplex virus glycoproteins gH/gL and gB bind Toll-like receptor 2, and soluble gH/gL is sufficient to activate NF-κBReversible conformational change in herpes simplex virus glycoprotein B with fusion-from-without activity is triggered by mildly acidic pH.{alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2.Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.Differential effects on cell fusion activity of mutations in herpes simplex virus 1 glycoprotein B (gB) dependent on whether a gD receptor or a gB receptor is overexpressedCross talk among the glycoproteins involved in herpes simplex virus entry and fusion: the interaction between gB and gH/gL does not necessarily require gD.Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and Hαvβ6- and αvβ8-integrins serve as interchangeable receptors for HSV gH/gL to promote endocytosis and activation of membrane fusion.Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity.The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its ReceptorsThe soluble amino-terminal region of HVEM mediates efficient herpes simplex virus type 1 infection of gD receptor-negative cells.Dissociation of HSV gL from gH by αvβ6- or αvβ8-integrin promotes gH activation and virus entry.The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulationA lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.Glycoprotein B of herpes simplex virus 2 has more than one intracellular conformation and is altered by low pH.Features of Human Herpesvirus-6A and -6B Entryαvβ3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1.Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and NucleusVaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.Characterization of white spot syndrome virus envelope protein VP51A and its interaction with viral tegument protein VP26Immunological control of herpes simplex virus infections.Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.Molecular pathogenesis and clinical implications of eczema herpeticum.
P2860
Q24619352-DE90B23E-1492-407F-853C-6A01EF52E83DQ24651228-0ECBFDAA-1FE1-4AA9-882B-B1D2BDC0223AQ26747534-1F82C1D8-04EE-48D4-9E62-E54693F1665EQ26765439-0D9141EE-3EEE-4B3C-B3AB-36EDA0633FF1Q28267511-1643F393-DA1B-4279-A516-A477ABCCDD06Q28473976-689287EB-D919-4898-91F3-A33D5F2FF805Q30432548-1556AB69-EFD8-4C2B-BDEF-69D4A0E352B4Q30473768-2CDD930B-3F54-49BD-B397-DAE399777D37Q33591823-AB0B59D8-E355-4006-BF0E-15EDAC6D6F31Q33614527-F04C1286-4243-4E36-8420-A87F5270451BQ33621028-B447552E-C0D7-46B8-B364-6E799265FFEFQ33769324-E66FA275-F4FB-43AE-9E18-CC2CAE53FDCBQ33802555-1262C4F7-205D-4705-8825-822DBFB04570Q33877322-307CA71F-DF87-4CB8-8933-A88366725C63Q34103593-612581AF-DC72-4F5A-A1C9-E0F7F78499A4Q34267595-33B81F27-942C-46D1-92EE-3211526E6E7BQ34412176-0931E232-705B-4EEE-9D03-EB642DE600EAQ34438552-D34F2B0F-8E6D-4631-BCB2-03A02244359DQ34574879-C143D0A6-3C80-45EC-9D1B-5EDA93D3997BQ34621654-243E256B-C37F-45FD-AD76-E49473BAE655Q34982160-B796DD8D-EB7C-4B14-8FBA-26EAA3B0F3ABQ34995805-A811DC10-65C5-4830-BB7B-AC9038352170Q35042295-9A43A488-49F4-4705-A847-336E1592331BQ35075118-B65A85D3-42BB-4519-AE71-958687E726BEQ35382962-000B70DD-6CDC-471F-AFB6-08CDC7F1940AQ35638350-D37C7012-81C7-4AC3-A83A-78DA7F27DD02Q35774736-74149756-B03D-41FA-9999-2AC34E2D5A3CQ35895648-70B8EB03-01A8-4199-AE54-B1FAD0962528Q36053977-676BD78C-26B0-4312-A35E-3D14520E90BEQ36086635-D7C52CAD-395B-40BE-B3D6-9747910FA425Q36086658-9CCE759B-2F8F-4E42-9B8B-B899B120EC10Q36362169-9EB7EC62-F4F3-422A-8284-53482C0D93DAQ36438385-23E047CC-C198-4098-868F-71890CC043D8Q36482815-7D2F6B98-B9CF-4D75-B770-76C932C98084Q36689670-B3EF95D5-42CF-4112-87B6-9C168112D613Q36694861-25F26F25-43E2-4DC9-AABA-727F372D51D0Q36994580-D7C1BE23-B351-4EC4-BA34-AB734D4AC444Q37135532-59522C8D-6065-49C4-903D-E4488A1FA809Q37198935-412D0B18-C1CB-499F-A73F-498B9694EE54Q37213870-229F5A2B-F69C-4423-95E3-B95F80E0C207
P2860
The multipartite system that mediates entry of herpes simplex virus into the cell.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The multipartite system that mediates entry of herpes simplex virus into the cell.
@en
type
label
The multipartite system that mediates entry of herpes simplex virus into the cell.
@en
prefLabel
The multipartite system that mediates entry of herpes simplex virus into the cell.
@en
P2093
P356
P1476
The multipartite system that mediates entry of herpes simplex virus into the cell.
@en
P2093
Arianna Cerretani
Cristina Forghieri
Elisa Avitabile
Laura Menotti
Michele Amasio
Tatiana Gianni
P304
P356
10.1002/RMV.546
P577
2007-09-01T00:00:00Z